Science Explorer Interactive view Map
Company · Oak Brook · United States

Epi-Q (United States)

epi-q.comROR OpenAlex
Research works
38
▲ 46% vs 2013–17
Citations
648
17.1 per fractional work
Top-10% rate
14.1%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Epi-Q (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.71× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.94× its world share, 0 worksImmunology and Micro…Neuroscience: 0.54× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.06× its world share, 0 worksPharmacology, Toxico…Engineering: 0.22× its world share, 0 worksEngineeringHealth Professions: 0.33× its world share, 0 worksHealth ProfessionsMedicine: 3.50× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 1.34× its world share, 0 worksEconomics, Econometr…Psychology: 0.18× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.7×. Every wedge is a field page.

Which keywords describe research at Epi-Q (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Immunotherapy, Guidelines, Substance Use Disorders, Health Policy, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Epidemiology6▲ 3.8×24 topics
  2. Quality of Life4▲ 7.9×13 topics
  3. Immunotherapy3▲ 11×10 topics
  4. Inflammation2▲ 2.6×10 topics
  5. Treatment2▲ 4.1×12 topics
  6. Guidelines2▲ 10×7 topics
  7. Substance Use Disorders2▲ 70×2 topics
  8. Health Policy2▲ 29×2 topics
  9. Public Health2▲ 3.3×4 topics
  10. Cost-effectiveness Analysis2▲ 55×1 topic
  11. Genetics2▲ 5.5×6 topics
  12. Health Utility Measures2▲ 55×1 topic
  13. Patient Satisfaction2▲ 16×4 topics
  14. Prognostic Factors2▲ 9.1×4 topics
  15. Rituximab2▲ 26×2 topics
  16. Antiretroviral Therapy1▲ 16×4 topics
  17. Diagnosis1▲ 3.6×7 topics
  18. Postoperative Pain1▲ 39×3 topics
  19. Pain Management1▲ 15×2 topics
  20. Primary Care1▲ 8.3×4 topics
  21. Tumor Regression1▲ 38×2 topics
  22. Cardiovascular Disease1▲ 2.9×5 topics
  23. Chronic Disease Management1▲ 21×2 topics
  24. Chronic Lymphocytic Leukemia1▲ 65×1 topic
  25. Genomic Aberrations1▲ 65×1 topic
  26. Inflammatory Bowel Disease1▲ 29×3 topics
  27. Chemotherapy1▲ 3.9×7 topics
  28. Clinical Practice Guidelines1▲ 5.3×4 topics
  29. Bacterial Therapy1▲ 60×1 topic
  30. Clinical Outcomes1▲ 13×4 topics
  31. Immunology1▲ 23×2 topics
  32. Nursing Advocacy1▲ 144×1 topic
  33. Political Participation1▲ 32×1 topic
  34. Tumor Targeting1▲ 20×1 topic

Which research topics does Epi-Q (United States) publish most on?

By volume in 2022–2025: Cancer Research and Treatments, Inflammatory Bowel Disease, Chronic Lymphocytic Leukemia Research and Empathy and Medical Education.

Cancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksInflammatory Bowel Disease1Inflammatory Bowel Disease: 1 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksEmpathy and Medical Educ…0Empathy and Medical Education: 0 fractional worksReproductive Health and …0Reproductive Health and Technologies: 0 fractional worksBladder and Urothelial C…0Bladder and Urothelial Cancer Treatments: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksPregnancy and Medication Impact: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksAlcoholism and Thiamine Deficiency: 0 fractional works
BiotechnologyGeneticsPsychiatry and Mental healthReproductive Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Research and Treatments Biotechnology 1 works
  2. 2 Inflammatory Bowel Disease Genetics 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Empathy and Medical Education Psychiatry and Mental health 0 works
  5. 5 Reproductive Health and Technologies Reproductive Medicine 0 works
  6. 6 Bladder and Urothelial Cancer Treatments Surgery 0 works
  7. 7 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  8. 8 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 0 works
  9. 9 Medication Adherence and Compliance Family Practice 0 works
  10. 10 Alcoholism and Thiamine Deficiency Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 28% of research is openly available.

with international co-authors15.6%domestic only84.4%

World: 19% is written across borders.

How has Epi-Q (United States)'s research output changed?

Output in 2018–2022 was 46% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Oak Brook

All research institutions in Oak Brook

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.